Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

François Franceschi

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Biochemical Pharmacology|January 31, 2006
Structure-based drug design meets the ribosomeFrançois Franceschi, Erin M Duffy
Annales Pharmaceutiques Francaises|December 16, 2024
[Development of a cost-satisfaction indicator for monitoring implantable medical devices on loan and in permanent storage]François Franceschi, Charlotte Debanne, Valérie Archer, et al.
Annales Pharmaceutiques Francaises|December 6, 2025
[Innovative medical devices in France: A descriptive study based on public healthcare databases]François Franceschi, Nicolas Martelli, Judith Pineau, et al.
Current Protein & Peptide Science|October 9, 2002
Initiation and inhibition of protein biosynthesis studies at high resolutionRaz Zarivach, Anat Bashan, Frank Schluenzen, et al.
Plos One|July 2, 2025
Carbapenem-resistant Enterobacterales among patients with bloodstream infections in South Africa: Consolidated surveillance data, 2015-2021Husna Ismail, Thembekile Buhle Christna Zwane, Elloise Du Toit, et al.
Antimicrobial Agents and Chemotherapy|July 30, 2008
R chi-01, a new family of oxazolidinones that overcome ribosome-based linezolid resistanceEugene Skripkin, Timothy S McConnell, Joseph DeVito, et al.
Paediatric Drugs|August 26, 2021
Potential Antibiotics for the Treatment of Neonatal Sepsis Caused by Multidrug-Resistant BacteriaChristopher A Darlow, Renata M A da Costa, Sally Ellis, et al.
Current Drug Targets. Infectious Disorders|December 5, 2002
Antibiotics targeting ribosomes: crystallographic studiesTamar Auerbach, Anat Bashan, Joerg Harms, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 18, 2020
Pharmacokinetic/pharmacodynamic considerations for new and current therapeutic drugs for uncomplicated gonorrhoea-challenges and opportunitiesUrsula Theuretzbacher, Lindley Barbee, Kristie Connolly, et al.
International Journal of Antimicrobial Agents|April 15, 2021
Systematic review and meta-analysis of in vitro efficacy of antibiotic combination therapy against carbapenem-resistant Gram-negative bacilliLuigia Scudeller, Elda Righi, Margherita Chiamenti, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Biochemical Pharmacology|January 31, 2006
Structure-based drug design meets the ribosomeFrançois Franceschi, Erin M Duffy
Annales Pharmaceutiques Francaises|December 16, 2024
[Development of a cost-satisfaction indicator for monitoring implantable medical devices on loan and in permanent storage]François Franceschi, Charlotte Debanne, Valérie Archer, et al.
Annales Pharmaceutiques Francaises|December 6, 2025
[Innovative medical devices in France: A descriptive study based on public healthcare databases]François Franceschi, Nicolas Martelli, Judith Pineau, et al.
Current Protein & Peptide Science|October 9, 2002
Initiation and inhibition of protein biosynthesis studies at high resolutionRaz Zarivach, Anat Bashan, Frank Schluenzen, et al.
Plos One|July 2, 2025
Carbapenem-resistant Enterobacterales among patients with bloodstream infections in South Africa: Consolidated surveillance data, 2015-2021Husna Ismail, Thembekile Buhle Christna Zwane, Elloise Du Toit, et al.
Antimicrobial Agents and Chemotherapy|July 30, 2008
R chi-01, a new family of oxazolidinones that overcome ribosome-based linezolid resistanceEugene Skripkin, Timothy S McConnell, Joseph DeVito, et al.
Paediatric Drugs|August 26, 2021
Potential Antibiotics for the Treatment of Neonatal Sepsis Caused by Multidrug-Resistant BacteriaChristopher A Darlow, Renata M A da Costa, Sally Ellis, et al.
Current Drug Targets. Infectious Disorders|December 5, 2002
Antibiotics targeting ribosomes: crystallographic studiesTamar Auerbach, Anat Bashan, Joerg Harms, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 18, 2020
Pharmacokinetic/pharmacodynamic considerations for new and current therapeutic drugs for uncomplicated gonorrhoea-challenges and opportunitiesUrsula Theuretzbacher, Lindley Barbee, Kristie Connolly, et al.
International Journal of Antimicrobial Agents|April 15, 2021
Systematic review and meta-analysis of in vitro efficacy of antibiotic combination therapy against carbapenem-resistant Gram-negative bacilliLuigia Scudeller, Elda Righi, Margherita Chiamenti, et al.
Pageof 2